The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
Open accessAbstract
The network for cardiac fuel metabolism contains intricate sets of interacting pathways that result in both ATP-producing and non–ATP-producing end points for each class of energy substrates. The most salient feature of the network is the metabolic flexibility demonstrated in response to various stimuli, including developmental changes and nutritional status. The heart is also capable of remodeling the metabolic pathways in chronic pathophysiological conditions, which results in modulations of myocardial energetics and contractile function. In a quest to understand the complexity of the cardiac metabolic network, pharmacological and genetic tools have been engaged to manipulate cardiac metabolism in a variety of research models. In concert, a host of therapeutic interventions have been tested clinically to target substrate preference, insulin sensitivity, and mitochondrial function. In addition, the contribution of cellular metabolism to growth, survival, and other signaling pathways through the production of metabolic intermediates has been increasingly noted. In this review, we provide an overview of the cardiac metabolic network and highlight alterations observed in cardiac pathologies as well as strategies used as metabolic therapies in heart failure. Lastly, the ability of metabolic derivatives to intersect growth and survival are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–218 of 218
Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter
Belke, D. D., Larsen, T. S., Gibbs, E. M., & Severson, D. L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.3.e420 · Cited by 48
Ananthakrishnan, R., Kaneko, M., Hwang, Y. C., Quadri, N., Gomez, T., Li, Q., Caspersen, C. S., & Ramasamy, R. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01012.2008 · Cited by 47
Antioxidant, EUK-8, Prevents Murine Dilated Cardiomyopathy
Kawakami, S., Matsuda, A., Sunagawa, T., Noda, Y., Kaneko, T., Tahara, S., Hiraumi, Y., Adachi, S., Matsui, H., Ando, K., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0204 · Cited by 42
Halbirk, M., Nørrelund, H., Møller, N., Schmitz, O., Gøtzsche, L. B.-H., Nielsen, R. R., Nielsen‐Kudsk, J. E., Nielsen, S. S., Nielsen, T. T., Eiskjær, H., et al. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00475.2010 · Cited by 40
Cardiomyocyte autophagy: metabolic profit and loss
Wang, Z. V., Ferdous, A., & Hill, J. A. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9350-y · Cited by 39
Xin, W., Wei, W., & Li, X. (2012) · Heart · doi:10.1136/heartjnl-2012-302119 · Cited by 38
Torre-Villalvazo, I., Gonzalez, F., Aguilar-Salinas, C. A., Tovar, A. R., & Torres, N. (2009) · Journal of Nutrition · doi:10.3945/jn.109.109769 · Cited by 38
Multiphasic triacylglycerol dynamics in the intact heart during acute in vivo overexpression of CD36
Carley, A. N., Bi, J., Wang, X., Banke, N. H., Dyck, J. R. B., O’Donnell, J. M., & Lewandowski, E. D. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m029991 · Cited by 36
Therapy of complex I deficiency: Peripheral neuropathy during dichloroacetate therapy
Kurlemann, G., Paetzke, I., Möller, H. E., Masur, H., Schuierer, G. R., Weglage, J., & Koch, H. G. (1995) · European Journal of Pediatrics · doi:10.1007/bf01957508 · Cited by 33
Schönekess, B. O., Brindley, P. G., & Lopaschuk, G. O. (1995) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-725 · Cited by 31
Effect of hyperinsulinemia on myocardial amino acid uptake in patients with coronary artery disease
McNulty, P. H., Jacob, R. J., Deckelbaum, L. I., & Young, L. H. (2000) · Metabolism · doi:10.1053/meta.2000.9510 · Cited by 29
Kudej, R. K., White, L. T., Kudej, A. B., Vatner, S. F., & Lewandowski, E. D. (2002) · Circulation · doi:10.1161/01.cir.0000039326.87475.98 · Cited by 28
De Toni, L., Strapazzon, G., Gianesello, L., Caretta, N., Pilon, C., Bruttocao, A., & Foresta, C. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346724 · Cited by 25 · cited 1×
“Modulation of this pathway with phosphodiesterase 5 inhibitors was related to increased mitochondrial biogenesis.(171) Treatment with the phosphodiesterase 5 inhibitors, sildenafil, improved cardiac index and right ventricular EF in patients with heart failure,(172) but additional studies are required to determine whe…”
MethodSexual dimorphism in cardiac triacylglyceride dynamics in mice on long term caloric restriction
Banke, N. H., Yan, L., Pound, K. M., Dhar, S. K., Reinhardt, H., Lorenzo, M. S. D., Vatner, S. F., & Lewandowski, E. D. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.11.014 · Cited by 24
Targets, trafficking, and timing of cardiac autophagy
Rotter, D., & Rothermel, B. A. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.001 · Cited by 23
Nutritional Status and Cardiac Autophagy
Ahn, J., & Kim, J. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.1.30 · Cited by 18
Update on PPAR agonists: The clinical significance of FIELD and PROACTIVE
Robinson, J. G. (2007) · Current Atherosclerosis Reports · doi:10.1007/bf02693930 · Cited by 12
[Dichloroacetate treatment for adult patients with mitochondrial disease].
Oishi, K., Yoshioka, M., Ozawa, R., Yamamoto, T., Oya, Y., Ogawa, M., & Kawai, M. (2003) · PubMed · Cited by 6
Cited by
Association between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
Jia, G., DeMarco, V. G., & Sowers, J. R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.216 · Cited by 949
Mitochondrial dysfunction in pathophysiology of heart failure
Zhou, B., & Tian, R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120849 · Cited by 923
Self-citationLipolysis: cellular mechanisms for lipid mobilization from fat stores
Grabner, G. F., Xie, H., Schweiger, M., & Zechner, R. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00493-6 · Cited by 765
Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1477-x · Cited by 708
Metadata
- Authors
- Kolwicz, S. C., Purohit, S., & Tian, R.
- Venue
- Circulation Research
- Published
- 2013-08-16
- Volume
- 113
- Issue
- 5
- Pages
- 603-616
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W1968550558
- Cited by
- 813
- References
- 218
- FWCI
- 21.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.